This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Impax Laboratories Inc (IPXL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 214.87M 184.61M 142.16M 104.42M
Receivables 146.49M 112.99M 92.25M 153.77M
Inventories 80.57M 70.11M 89.76M 54.18M
Other Current Assets 0.00 0.00 0.00 1.41M
Total Current Assets 730.45M 659.74M 545.54M 599.94M
Property, Plant & Equipment, Gross 304.36M 287.81M 267.52M 192.96M
Accumulated Depreciation & Depletion 116.19M 99.62M 86.76M 74.80M
Property, Plant & Equipment, Net 188.17M 188.19M 180.76M 118.16M
Intangibles 26.71M 29.67M 47.95M 0.00
Other Non-Current Assets 64.46M 57.82M 42.75M 40.76M
Total Non-Current Assets 348.75M 337.18M 318.43M 193.92M
Liabilities & Shareholder Equity
Total Assets 1.08B 996.92M 863.97M 793.86M
Accounts Payable 31.98M 26.82M 41.34M 22.96M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 15.39M 0.00 1.54M 1.13M
Total Current Liabilities 158.70M 153.89M 145.30M 156.86M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 32.62M 32.83M 27.57M 33.99M
Minority Interest 0.00 0.00 0.00 -97.00K
Total Non-Current Liabilities 32.62M 32.83M 27.57M 34.06M
Total Liabilities 191.32M 186.72M 172.87M 190.92M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 887.88M 810.20M 691.10M 602.94M
Common Par 714.00K 699.00K 685.00K 667.00K
Additional Paid In Capital 364.10M 336.65M 314.72M 285.97M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 531.23M 473.87M 372.61M 316.74M
Treasury Stock -2.16M -2.16M -2.16M -2.16M
Other Equity Adjustments -6.01M 1.14M 5.24M 1.72M
Total Capitalization 887.88M 810.20M 691.10M 602.94M
Total Equity 887.88M 810.20M 691.10M 602.94M
Total Liabilities & Stock Equity 1.08B 996.92M 863.97M 793.86M
Total Common Shares Outstanding 71.23M 69.68M 68.27M 66.50M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 243.73K 243.73K 243.73K 243.73K
Basic Weighted Shares Outstanding 68.19M 66.92M 65.66M 64.13M
Diluted Weighted Shares Outstanding 70.53M 68.66M 68.40M 67.32M
Number of Employees 1061 973 1125 1002
Number of Part-Time Employees 0 0 0 0
IPXL News

IPXL Impax Laboratories Inc

Analysts Ratings for IPXL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 0 0
Moderate Buy 1 1 1 1
Hold 8 7 7 6
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET IPXL ANALYST REPORT

Brokerage Partners

IPXL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs